Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
Elizabeth M. Rhea, William A. Banks
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 203

Showing 26-50 of 203 citing articles:

Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer
Xudong Cai, Calum J. Drummond, Jiali Zhai, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 12
Brain insulin resistance and Alzheimer’s disease: a systematic review
Luís Jesuíno de Oliveira Andrade, Luís Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, et al.
Dementia & Neuropsychologia (2024) Vol. 18
Open Access | Times Cited: 11
The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance
William A. Banks, Elizabeth M. Rhea
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1695-1695
Open Access | Times Cited: 55
B3Pred: A Random-Forest-Based Method for Predicting and Designing Blood–Brain Barrier Penetrating Peptides
Vinod Kumar, Sumeet Patiyal, Anjali Dhall, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1237-1237
Open Access | Times Cited: 54
The Causes and Long-Term Consequences of Viral Encephalitis
Karen Böhmwald, Catalina A. Andrade, Nicolás M. S. Gálvez, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 46
Solid Lipid Nanoparticles of Curcumin Designed for Enhanced Bioavailability and Anticancer Efficiency
Sooho Yeo, Min Je Kim, Young Key Shim, et al.
ACS Omega (2022) Vol. 7, Iss. 40, pp. 35875-35884
Open Access | Times Cited: 29
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
Megan Ritson, Caroline Wheeler‐Jones, Helen B. Stolp
Journal of Neuroimmunology (2024) Vol. 391, pp. 578363-578363
Open Access | Times Cited: 6
The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms and Approaches to Treatment
William A. Banks
Current Pharmaceutical Design (2020) Vol. 26, Iss. 13, pp. 1438-1447
Closed Access | Times Cited: 43
Central actions of insulin during pregnancy and lactation
Sharon R. Ladyman, Virginia L. Brooks
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 4
Open Access | Times Cited: 40
ApoE and cerebral insulin: Trafficking, receptors, and resistance
Elizabeth M. Rhea, Jacob Raber, William A. Banks
Neurobiology of Disease (2020) Vol. 137, pp. 104755-104755
Open Access | Times Cited: 39
From obesity to Alzheimer's disease through insulin resistance
Simona Terzo, Antonella Amato, Flavia Mulè
Journal of Diabetes and its Complications (2021) Vol. 35, Iss. 11, pp. 108026-108026
Open Access | Times Cited: 39
Pericytes Across the Lifetime in the Central Nervous System
Hannah Bennett, Yongsoo Kim
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 36
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome
Chiara Lanzillotta, Antonella Tramutola, Graziella Di Giacomo, et al.
Free Radical Biology and Medicine (2021) Vol. 165, pp. 152-170
Closed Access | Times Cited: 33
Central nervous system insulin signaling can influence the rate of insulin influx into brain
Văn Hùng Nguyễn, P. C. Thomas, Sarah Pemberton, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Drug delivery to the brain – lipid nanoparticles-based approach
Viliana Gugleva, Velichka Andonova
Pharmacia (2023) Vol. 70, Iss. 1, pp. 113-120
Open Access | Times Cited: 13
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access
Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease
Feng-Qing Xu, Jingshan Shi
Journal of Alzheimer s Disease (2025)
Closed Access
Neuropathological changes in the nucleus basalis of Meynert in people with type 1 or type 2 diabetes mellitus.
Wei Jiang, Martin J. Kalsbeek, Felipe Corrêa‐da‐Silva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Acetaldehyde dehydrogenase 2 attenuates lipopolysaccharide -induced endothelial barrier damage by inhibiting mitochondrial fission in sepsis-associated encephalopathy
Shasha Wang, Zhongyi Liu, Rong Li, et al.
European Journal of Pharmacology (2025), pp. 177468-177468
Closed Access
Molecular Motors in Blood–Brain Barrier Maintenance by Astrocytes
Ana Filipa Sobral, Inês Costa, Vanessa Teixeira, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 279-279
Open Access
Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine
Marie Karam, Alba Ortega-Gascó, Daniel Tornero
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3275-3275
Open Access
Machine learning study on predicting depressive symptoms and genetic correlations in Parkinson’s disease
Haijun Zhang, Yifan Zhang, Guoqiang Li
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
The relationship between triglyceride-glucose index and serum neurofilament light chain: Findings from NHANES 2013–2014
Tong Chen, Wei Zheng, Yan Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321226-e0321226
Open Access
Panax notoginseng saponins suppress lipopolysaccharide‐induced barrier disruption and monocyte adhesion on bEnd.3 cells via the opposite modulation of Nrf2 antioxidant and NF‐κB inflammatory pathways
Shaonan Hu, Tingting Liu, Yali Wu, et al.
Phytotherapy Research (2019) Vol. 33, Iss. 12, pp. 3163-3176
Closed Access | Times Cited: 39

Scroll to top